Recognizing July 28, 2025, as "World Hepatitis Day".

Bill Number: H.Res. 630
Origin Chamber: House
Congress: 119th Congress, Session 1
Policy Area: Health
Status: Introduced
Latest Action: 2025-08-01: Referred to the House Committee on Energy and Commerce.
Last Updated: 2025-09-12T16:38:37Z

AI-Generated Summary

Purpose

This House Resolution (H. Res. 630) aims to formally recognize July 28, 2025, as "World Hepatitis Day." It highlights the global and U.S.-specific challenges of hepatitis B and C viruses, which cause liver disease and death. The resolution seeks to raise awareness, promote prevention and treatment, and encourage public health actions to address these infections, emphasizing their preventable and treatable nature.

Key Provisions

The resolution includes extensive background ("Whereas" clauses) on hepatitis statistics and challenges, followed by specific actions for the House of Representatives:

Recognition of World Hepatitis Day: Acknowledges the day to spotlight the worldwide hepatitis epidemics.
Support for Access to Care: Endorses widespread availability of hepatitis B vaccinations and hepatitis C treatments.
Awareness Efforts: Promotes education on the risks and impacts of undiagnosed chronic hepatitis B and C infections.
Call for Response: Urges a strong government and public health effort to protect the estimated 5.9 million people in the U.S. affected by these viruses.
Partnership Recommendation: Encourages the Centers for Disease Control and Prevention (CDC) to collaborate with state and local health departments on strategies to boost adult hepatitis B vaccination rates and hepatitis C treatment, aiming to eliminate new infections.

Significant Changes to Existing Law

This is a non-binding resolution, so it introduces no changes to existing laws or regulations. It expresses the House's stance but does not create enforceable mandates, allocate funds, or alter statutes.

Potential Impacts

On Government Agencies: May encourage the CDC, Department of Health and Human Services, and local health departments to prioritize hepatitis initiatives, such as expanded screening, vaccination, and data surveillance, though without legal requirements.
On Citizens: Could increase public awareness, leading to more testing, vaccinations, and treatments, particularly for at-risk groups like people who inject drugs, racial/ethnic minorities, and those with HIV. It highlights disparities in infection rates and access to care.
On International Relations: Supports global efforts by recognizing the worldwide scale of hepatitis (e.g., 1.34 million annual deaths globally), potentially aligning U.S. public health messaging with international campaigns without direct diplomatic effects.

Main Stakeholders Affected

At-Risk Populations: Includes people who inject drugs (accounting for over 70% of new hepatitis C cases), African Americans, Asian Americans, Pacific Islanders, Latinos, Native Americans, Alaska Natives, gay and bisexual men, and individuals with HIV (where hepatitis co-infections are common).
Public Health Organizations: CDC, state/local health departments, and community-based groups involved in testing, vaccination, and outreach, which have faced funding cuts and service reductions.
Healthcare Providers and Patients: Doctors, clinics, and the estimated 5.9 million U.S. individuals infected (many undiagnosed), benefiting from calls for better access to curable treatments and vaccines.
General Public: All Americans, as the resolution addresses rising infection rates (e.g., 63% increase in acute hepatitis C from 2015-2019) and promotes prevention to reduce overall liver disease burden.

Notable Legal, Constitutional, or Political Implications

Legal: As a simple resolution, it has no force of law and requires no presidential approval; it solely reflects House sentiment and could influence future appropriations or bills on public health.
Constitutional: Aligns with Congress's role in informing public policy on health matters under its general welfare powers (Article I, Section 8), without infringing on individual rights.
Political: Signals bipartisan support (introduced by Reps. Velázquez and Johnson) for addressing health inequities and the national strategic plan to eliminate viral hepatitis. It may build momentum for funding hepatitis programs amid competing priorities, emphasizing a "syndemic" approach (treating interconnected health issues like hepatitis, HIV, and substance use together).

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Velázquez, Nydia M. [D-NY-7]

Cosponsors (1)

Rep. Johnson, Henry C. "Hank" [D-GA-4]

Recent Actions

2025-08-01: Referred to the House Committee on Energy and Commerce.
2025-08-01: Submitted in House
2025-08-01: Submitted in House

Bill Versions

Recognizing July 28, 2025, as "World Hepatitis Day". — issued 2025-08-01 — PDF (5 pages)